These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 16495798

  • 21. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization.
    Maddala YK, Stadheim L, Andrews JC, Burgart LJ, Rosen CB, Kremers WK, Gores G.
    Liver Transpl; 2004 Mar; 10(3):449-55. PubMed ID: 15004776
    [Abstract] [Full Text] [Related]

  • 22. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.
    Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP.
    Liver Transpl; 2003 Jul; 9(7):684-92. PubMed ID: 12827553
    [Abstract] [Full Text] [Related]

  • 23. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
    Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, Costa AN, Nardi A, Strazzabosco M, Burra P, Agnes S, Baccarani U, Calise F, Colledan M, Cuomo O, De Carlis L, Donataccio M, Ettorre GM, Gerunda GE, Gridelli B, Lupo L, Mazzaferro V, Pinna A, Risaliti A, Salizzoni M, Tisone G, Valente U, Rossi G, Rossi M, Zamboni F, Liver Match Investigators.
    Dig Liver Dis; 2011 Feb; 43(2):155-64. PubMed ID: 21185796
    [Abstract] [Full Text] [Related]

  • 24. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K, Feng S.
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [Abstract] [Full Text] [Related]

  • 25. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.
    Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD, Magee JC, Lok AS, Fontana RJ, Marrero JA.
    Liver Transpl; 2009 Aug; 15(8):859-68. PubMed ID: 19642139
    [Abstract] [Full Text] [Related]

  • 26. Preliminary results of liver transplantation for hepatocellular carcinoma among allocation organ policy strategies, neoadjuvant treatments, and intention-to-treat analysis.
    Andorno E, Bottino G, Morelli N, Casaccia M, Gelli M, Piredda D, Immordino G, Ferrante R, Nardi I, Troilo BM, Di Domenico S, Ravazzoni F, Valente U.
    Transplant Proc; 2008 Aug; 40(6):1972-3. PubMed ID: 18675103
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC, Baracat EI, Massarollo PC, Pereira LA, Szutan LA.
    Transplant Proc; 2013 Aug; 45(6):2111-4. PubMed ID: 23747144
    [Abstract] [Full Text] [Related]

  • 29. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.
    Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP.
    Liver Transpl; 2002 Oct; 8(10):873-83. PubMed ID: 12360427
    [Abstract] [Full Text] [Related]

  • 30. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
    Takahashi S, Kudo M, Chung H, Inoue T, Nagashima M, Kitai S, Tatsumi C, Minami Y, Ueshima K, Fukunaga T, Haji S.
    Dig Dis; 2007 Oct; 25(4):303-9. PubMed ID: 17960064
    [Abstract] [Full Text] [Related]

  • 31. Value of the MELD score for the assessment of pre- and post-liver transplantation survival.
    Adler M, De Gendt E, Vereerstraeten P, Degré D, Bourgeois N, Boon N, Gelin M, Ickx B, Donckier V.
    Transplant Proc; 2005 Oct; 37(6):2863-4. PubMed ID: 16182835
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The role and limitation of living donor liver transplantation for hepatocellular carcinoma.
    Lo CM, Fan ST, Liu CL, Chan SC, Wong J.
    Liver Transpl; 2004 Mar; 10(3):440-7. PubMed ID: 15004774
    [Abstract] [Full Text] [Related]

  • 34. Current controversies surrounding liver transplantation for hepatocellular carcinoma.
    Silva MF, Wigg AJ.
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1217-26. PubMed ID: 20594247
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ, Pappas L, Thiesset HF, Vargas G, Sorensen JB, Kim RD, Hutson WR, Boucher K, Box T.
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [Abstract] [Full Text] [Related]

  • 38. Liver transplantation for hepatocellular carcinoma: defining the impact of using extended criteria liver allografts.
    Facciuto ME, Singh MK, Katta U, Samaniego S, Sharma J, Rodriguez-Davalos M, Sheiner P, Kim-Schluger L, Wolf DC.
    Transplantation; 2011 Aug 27; 92(4):446-52. PubMed ID: 21694662
    [Abstract] [Full Text] [Related]

  • 39. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN, Perkins JD, Carithers RL.
    Gastroenterology; 2008 May 27; 134(5):1342-51. PubMed ID: 18471511
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.